Rhonda Farnum sold $583K of Theravance Biopharma (TBPH)

Executed Dec 3 2025, disclosed Dec 5 2025, 2 days later.

Value, as filed

$583K

31,067 sh across 3 lots

Executed

Dec 3 2025

the trade date, as filed

Disclosed

Dec 5 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

RF Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS profile →

Rhonda Farnum (SVP, COMM & MEDICAL AFFAIRS) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Theravance Biopharma, Inc. (TBPH). The largest single filing was $583K of TBPH (31,067 sh across 3 lots, as filed), executed Dec 3 2025.

The name

TBPH Theravance Biopharma, Inc. TBPH · Healthcare · 10 filings in 24 months ticker →

Healthcare · Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Rhonda Farnum in TBPH

TBPHSALE Theravance Biopharma, Inc. $113K
6,657 sh × $17.03
Exec Sep 15
Filed Sep 17 · 5:52 PM ET TBPHSALE Theravance Biopharma, Inc. $109K
6,657 sh × $16.39
Exec Jun 15
Filed Jun 17 · 5:30 PM ET TBPHSALE Theravance Biopharma, Inc. $434K
31,067 sh across 3 lots
Exec Mar 16
Filed Mar 18 · 5:30 PM ET TBPHSALE Theravance Biopharma, Inc. $264K
24,000 sh × $11.00
Exec Jun 2 2025
Filed Jun 4 2025 · 5:30 PM ET